Guest guest Posted December 11, 2006 Report Share Posted December 11, 2006 http://www.house.gov/ed_workforce/hearings/106th/oi/ritalin92900/fassl er.htm UNITED STATES HOUSE OF REPRESENTATIVES COMMITTEE ON EDUCATION AND THE WORKFORCE HEARING ON: " Behavioral Drugs in Schools: Questions and Concerns " INTRODUCTION " ...My name is Fassler. I'm a Board Certified Child and Adolescent Psychiatrist practicing in Burlington, Vermont and Chairperson of the American Psychiatric Association's Committee on Children, Adolescents and Families.... " Oh dear. " ...I have with me for the Committee, The Diagnostic and Statistical Manual of Disorders IV-R which is central to understanding and diagnosing ADHD....blah blah unscientific psychobabble blah... " BUT TO BE FAIR TO HIM.... http://www.usatoday.com/news/washington/2005-04-25-drug-lobby- cover_x.htm " ...A third witness, child and adolescent psychiatrist Fassler, called for greater public access to clinical trial data for drugs. .... " OR PERHAPS NOT " ...But he expressed concern that FDA action last year to require a " black-box warning " on antidepressants prescribed for children and adolescents might deter families from seeking medications.... " Respond to this message Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.